Psycho-social predictors for noncompliance to chronic drug treatment in Crohn's disease

Author(s):  
Batel Lasry
2017 ◽  
Vol 152 (5) ◽  
pp. S795
Author(s):  
Doron Schwartz ◽  
Batel Lasry ◽  
Moataz Abo Abod ◽  
Dan Greenberg ◽  
Michael Friger ◽  
...  

1978 ◽  
Vol 74 (5) ◽  
pp. 1100 ◽  
Author(s):  
R.W. Summers ◽  
J.T. Sessions ◽  
D.M. Switz ◽  
J.W. Singleton

The Lancet ◽  
1975 ◽  
Vol 306 (7945) ◽  
pp. 1149-1150 ◽  
Author(s):  
R Darragh Montgomery

The Lancet ◽  
1975 ◽  
Vol 306 (7947) ◽  
pp. 1260 ◽  
Author(s):  
D.J. Holdstock

2015 ◽  
Vol 2015 ◽  
pp. 1-2 ◽  
Author(s):  
Michele Sorleto ◽  
Stefanie Dürrwald ◽  
Marcus Wiemer

Mesalazine- (5-aminosalicylic acid-) containing products are a well-known treatment for inflammatory bowel disease, often as first line. Myocarditis is recognized as a very rare possible side effect of this drug treatment. We present a case of mesalazine-induced myopericarditis that was successfully improved by immediate cessation of the medication.


1984 ◽  
Vol 86 (2) ◽  
pp. 249-266 ◽  
Author(s):  
H. Malchow ◽  
K. Ewe ◽  
J.W. Brandes ◽  
H. Goebell ◽  
H. Ehms ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document